Zubir Ahmed MP: speeches 2026

Speeches

• 15 Apr 2026 · Draft Health and Social Care Act 2008 (Regulated Activities) (Amendment) Regulations 2026 · Hansard source

  More

  The hon. Lady knows that I often indulge her interventions, but not today. These regulations are a response to a public inquiry and are designed to ensure that the CQC has the scope and oversight of events and arenas. It is for the CQC over the next 15 months to provide some of these definitions and clarity, and they are absolutely the right people to do it. On that basis, I ask colleagues to support this very necessary measure to protect those the people we were elected to serve. Question put.

• 14 Apr 2026 · National Suicide Prevention Standard · Hansard source

  More

  My hon. Friend is always knowledgeable about these matters and she tempts me to egress across the confines of my departmental portfolio. I am happy to cite her recommendations in my correspondence with colleagues in the Department for Business and Trade when I try and set up a meeting for my hon. Friend the Member for Blaydon and Consett. The role of employers generally cannot be understated. As the suicide prevention strategy clearly sets out, by improving support practices and conversations employers can and do save lives from suicide. Almost three quarters of people who take their own lives are not in contact with NHS mental health services. That points to the importance of public and private sector organisations—well beyond the confines of what we see as the traditional NHS—that are well placed to reach those vulnerable people most at risk. Workplaces provide the perfect opportunity to signpost people to the support they need. Employers should support practices and conversations that help to prevent suicides—for example, by having employment assistance programmes, line manager training and support networks in place for employees. Every employee should feel supported, and every employer should ensure that support is known of and available to their staff. As has been highlighted, we know that some sectors are disproportionately affected by suicide. For example, suicide rates in construction are four times higher than in other business sectors. The Construction Leadership Council’s mental health project has focused, through the lens of prevention, on identifying the primary root mental health causes impacting construction workers. The project, in partnership with Mates in Mind and the University of Warwick, held a series of regional focus groups with on-the-ground workers and identified those causes as including late payments, a lack of stable work, and workers having to travel and stay far away from family and loved ones. The Department for Business and Trade consulted on those issues and received around 3,000 responses. An action plan, together with a joint code of practice setting out how employers across the sector can provide a more supportive environment to address and prevent those issues specifically, will be published this summer. With suicide prevention, we often talk about the importance of meeting people where they are. Ensuring that people are supported by their workplaces is one valuable way of doing that, and the Government are committed to finding more opportunities to ensure that every person requiring support can access it readily. For example, my counterpart Baroness Merron, alongside co-chairs Money and Mental Health, convened senior stakeholders from financial services to discuss the role they could play in supporting people at risk—both their customers and their employees. I understand there was a great appetite in the room to take further action on this matter, and Baroness Merron is working closely with officials to progress this work at pace. I encourage all workplaces and employers to familiarise themselves, and align their work practices, with the Government’s suicide prevention strategy and to consider how they can best support their staff. I would also encourage them to consider drawing on the BSI standards as an exemplar tool to help embed suicide prevention in working practices. Finally, as the BSI standard highlights, the importance of community, both inside and outside the workplace, cannot be overstated. That is why so many of the Government’s ambitions surrounding suicide prevention, and indeed wider prevention, hold community at their core. With our 10-year health plan, we are shifting care and support from traditional institutions into the community, and our focus is more firmly on prevention. Through the new community-based mental health centres that are being piloted, people and families can receive care and treatment when they need it, in their community, 24 hours a day, and in a much calmer environment than one finds in traditional A&E departments.

• 14 Apr 2026 · National Suicide Prevention Standard · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Mr Stringer. I thank my hon. Friend the Member for Blaydon and Consett (Liz Twist) for securing this debate on a topic that is especially close to her heart and for her work more generally to promote action on suicide prevention. I am also grateful to hon. Members across the Chamber for their interventions. Every suicide is nothing short of a tragedy. It has lasting and devastating impacts on families, friends and communities. Ensuring that the right care and support are available to someone who may be struggling when and where they need it can make all the difference in saving a life. That is why reducing the numbers of lives lost to suicide is a key priority for this Government, and we are committed to taking forward the suicide prevention strategy for England. The strategy focuses on harnessing efforts across civil society to help identify and support people at risk. Standards such as the one produced by the British Standards Institution play an important role in raising the profile of suicide prevention in England and in supporting employers to play their part. I take this opportunity to congratulate the BSI on 125 years of tireless work, ensuring quality not only in British society, but across the world. The British Standards Institution is the UK’s national standards body—an independent organisation that develops standards that shape and encourage best practice across myriad professional sectors. The Government’s relationship with the BSI is through a memorandum of understanding, primarily to support the UK standards system, rather than to direct or enforce implementation of standards by businesses. Decisions on adoption and implementation remain with individual organisations, although the Government may play a role in encouraging awareness of those standards to support best practice. In November last year, as we heard, the BSI launched a new voluntary standard entitled “Suicide and the Workplace”. That standard was particularly notable, given that it was not just the UK’s but the world’s first national standard supporting suicide prevention efforts in the workplace—a truly commendable achievement. My ministerial counterpart, the Minister with responsibility for mental health and women’s health, Baroness Gillian Merron, was particularly pleased to speak at the launch of that standard. As with other BSI standards, this voluntary British standard is published as guidance; it is designed to support organisations of any size and across all sectors in strengthening their approach to suicide prevention, intervention and bereavement support in the workplace. On uptake, I was pleased to hear that the standard has been well received so far, with more than 11,000 downloads since its publication in November. It is overwhelming to hear that businesses across the country are putting the standard into practice, including Heathrow airport and Inclusion Education, which have publicly adopted it. The standard is advisory and is intended to be integrated into existing organisational policies and health, safety and wellbeing arrangements, and therefore to be flexible. In terms of supporting its implementation, decisions on how to use it rest with individual organisations, but the Government recognise that some employers may choose to use it as a reference point or benchmark alongside their existing workplace mental health and wellbeing policies. My hon. Friend the Member for Blaydon and Consett knows I am not a Department for Business and Trade Minister, but I am committed to making sure that she is linked in with the appropriate Minister in that Department, particularly around her asks on how smaller and medium-sized enterprises can access and implement the standard and overcome the regulatory and financial hurdles to doing so, and I would be delighted to try to organise that meeting for her.

• 14 Apr 2026 · National Suicide Prevention Standard · Hansard source

  More

  My hon. Friend is trying to steal the conclusion of my speech, so I will bring it forward. I am always delighted to meet her, and she knows I am happy to contribute to any roundtable that she feels needs my attendance. I can charge my officials with the task of getting that organised. Those community-based mental health centres are co-delivered with primary care specialist services that can be drawn on as required. People can receive psychological therapies, medication and other interventions, while also having access to expertise that can help with wider issues that may be impacting on their wellbeing and recovery, such as issues with housing, employment and peer support. Our suicide prevention support pathfinder programme for middle-aged men will invest up to £3.6 million over three years in areas of England where middle-aged men face the greatest risk of suicide. It will support new ways of embedding effective, tailored support for middle-aged men within their communities and will create clearer, more joined-up pathways into existing local suicide prevention systems. Today’s discussion has without doubt highlighted that suicide prevention truly is everybody’s business. Every person, organisation and service has a role to play. We can all do more to ensure that we are equipped with the skills that can and will save lives. Our suicide prevention strategy sets out a comprehensive, evidence-driven plan to reduce the number of lives lost to suicide across our country. It highlights the important role that employers and organisations can and should play in supporting their staff to get the support they need. Guidance such as the BSI’s “Suicide and the Workplace” standard brings welcome visibility to just how important that role is. I extend my thanks to everyone who contributed to and was involved in the development of the standard. In conclusion, I know how personally painful debates such as this can be, but all hon. Members will know that the impact of these discussions goes well beyond the four walls of our Parliament and into the streets. That awareness is so important, and I am grateful to my hon. Friend the Member for Blaydon and Consett for securing this debate. I would be delighted to meet her and to organise the meetings I outlined. Question put and agreed to.

• 14 Apr 2026 · Topical Questions · Hansard source

  More

  I commend the community groups in the hon. Gentleman’s constituency. He will know that there are record amounts of funding going into mental health provision under this Government. We are committed to ensuring that that funding is disseminated into the community, by moving more services from hospitals into the community.

• 14 Apr 2026 · Topical Questions · Hansard source

  More

  My hon. Friend may know that in Scotland there is no NHS app. In England, where there is one, we can facilitate bowel cancer screening through the app, increase uptake, and save more lives. In Scotland, all the SNP has managed to provide in 20 years is, possibly, some dermatology services in Lanarkshire. When we came into power—

• 14 Apr 2026 · Topical Questions · Hansard source

  More

  I am grateful to my hon. Friend for making these points about haemophilia care. We are committed to implementing all recommendations of the review, and good progress has been made, including on non-plasma-derived treatments and the revision of the national service provision. NHS England and the Department of Health and Social Care will continue to provide updates on the Government response. I am happy to meet my hon. Friend to discuss this.

• 14 Apr 2026 · Topical Questions · Hansard source

  More

  Anyone receiving mental health treatment, in particular acute mental health treatment, deserves dignity and high-quality care. Where care falls short, this Government’s approach is that sunlight is the best disinfectant. That is why we are absolutely committed to learning, and to taking action to protect patients and improve in-patient mental health care up and down the country. I am deeply distressed to hear about this case and about other cases, including at St Andrew’s. NHS England and the Care Quality Commission are acting to keep patients safe. I am happy to take forward any further discussions with the hon. Lady, as necessary.

• 14 Apr 2026 · Mental Health Services · Hansard source

  More

  The case that the hon. Gentleman highlights is indicative of the fact that much work has been done and much more needs to be done. We are providing early intervention for children’s mental health and wellbeing by rolling out mental health support teams, which will happen in every school by 2029. We are investing £13 million to pilot enhanced training for staff, so that they can offer more support to young people with complex needs. We are ensuring that, as we are digitally transforming, children and adults can access talking therapies where required. A lot has been done and there is a lot more to do, and we will carry on doing it.

• 14 Apr 2026 · Mental Health Services · Hansard source

  More

  Mental health funding will rise by £140 million in real terms this year, reaching a record £16.1 billion. That is on top of capital investment of £473 million over four years to deliver new models of care and digital transformation. However, improving mental health services is about more than money because, despite the money from the last Government, they presided over a dramatic increase in mental health distress and waiting lists spiralling out of control. This Government will combine investment with reform to reduce waiting times, improve the quality of care, and strengthen prevention and early intervention.

• 14 Apr 2026 · Eating Disorders · Hansard source

  More

  I am grateful to my hon. Friend for highlighting those cuts and the devastating impact they had, particularly on mental health and eating disorder services. She is absolutely right that we have to do a lot more on the pathways, including harmonising some of the data and clinical coding to make sure that we are catching people early in the process. As I said, the prevalence review will now focus on eating disorders as well—that is a welcome intervention—and of course, children become adults, so we must end the cliff edge at the age of 18 and make sure that care continues in a holistic fashion. We are getting on with that.

• 14 Apr 2026 · Eating Disorders · Hansard source

  More

  The hon. Gentleman is absolutely right. The Government are conducting a consultation to examine the most effective ways that we can go further to ensure that children have healthy online experiences. The three-month consultation, which is evidence-led and has input from independent experts, will include determining the right minimum age for children to access social media, and it will report in the summer.

• 14 Apr 2026 · Eating Disorders · Hansard source

  More

  We all recognise the devastating impact that eating disorders have on people’s lives, so this Government are committed to going further. Increases in mental health spending, which reaches a record £16.1 billion this year, include funding for eating disorder care. We have also commissioned an independent review to better understand rising prevalence, and the interim report of that review highlights the worrying rise in the prevalence of eating disorders. We look forward to the final report, which will set out recommendations on improving support.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  I am very grateful to my hon. Friend. He always channels personal experience in such a productive way and he is a credit to this House in the way he conducts himself. I remember his maiden speech with great fondness in that regard. I do agree, and I will come later in my speech to how we can maintain quality more persistently across the whole system. Access to temporary wheelchair provision to support hospital discharge is also determined locally by ICBs. We recognise that elements of the NHS—despite it being on the road to recovery—are functioning below par and that many people are waiting too long to access equipment such as wheelchairs. During the pandemic, some wheelchair services experienced lower referral rates, which led to a surge in referrals post pandemic. Because of that, providers not only reduced their services but now, of course, face a backlog of referrals. That has meant unacceptable waiting times for both adults and—sadly—children, and those have fluctuated as services work to recover. However, action is being taken to address waiting times in England. In October 2025, we published the NHS medium-term planning framework, requiring all ICBs and community health services to actively manage and reduce waits above 18 weeks and to develop a plan to eliminate all 52-week waits. The community health services situation report will be used to monitor ICB performance against waiting-time targets in 2026-27, and it currently monitors waiting times for children, young people and adults under “Wheelchair, orthotics, prosthetics and equipment”. These targets will guide the system to reduce the longest waits first.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  Mr Betts, it is a pleasure to serve under your chairmanship. I start by thanking the hon. Member for Aberdeenshire North and Moray East (Seamus Logan) for securing the debate, as well as all Members who contributed. We, of course, want disabled people to access and experience healthcare services on an equitable footing and to have a healthcare service that is responsive to their needs. That includes making sure that they have the right equipment at the right time to maintain independence for as long as possible, whether that means wheelchairs, mobility aids or other assistive technologies. We recognise the profound impact that delays in receiving disability equipment have on people’s quality of life, and I will set out the action that the Government are taking. Before I do so, however, I want to take a moment to acknowledge the points raised by the hon. Members for Tiverton and Minehead (Rachel Gilmour) and for Mid Sussex (Alison Bennett), particularly the cases they raised. I will certainly ensure that I take a personal interest in the case described by the hon. Member for Tiverton and Minehead and that the relevant DWP Minister also has an opportunity to address that particularly harrowing case. The Liberal Democrat Front Bencher, the hon. Member for Epsom and Ewell (Helen Maguire), asked for an update on the Design for Life statistics on recycling and reusing, and I will get my officials to get back to her on that. We are committed to ensuring that disabled people have access to the services and support that they need. The Opposition spokesperson, the hon. Member for Hinckley and Bosworth (Dr Evans), asked about our NHS reforms and whether that might be an opportunity to think about better end-to-end commissioning and strategising on the topic. I can assure him that those conversations are being had both in the context of disability and, with regard to special educational needs and disabilities, in the Department for Education. There are a number of topics that, if we are honest with ourselves, have been often neglected in the last couple of decades and have a material impact on the quality of life for disabled people, sometimes for want of very simple changes to practice and, potentially, legislation, so I am very happy to take that on board with the Bill team. The reforms that we are taking forward in the health and social care space will hopefully help us to achieve what I have outlined. The 10-year health plan specifically identifies disabled people as a priority group for the development of neighbourhood healthcare, offering more holistic and ongoing support. We are making £4.6 billion of additional funding available for adult social care in 2028-29, compared with ’25-26, to support the sector in making some of those improvements. In July ’25, the Government announced that they would develop a new plan for disability, setting out a clear vision to break down barriers to opportunity for disabled people. That of course aligns with every Department having a Minister responsible for disability. We meet regularly to discuss challenges, particularly some of the ones highlighted during this debate, which often do not fit neatly into one Department’s purview. As hon. Members will be aware, health and social care are largely devolved across the UK. I will talk mainly about England, but of course I am the representative of a Scottish constituency, like the hon. Member who opened the debate, and he will understand if I just mention that we are committed, through the Barnett formula, to funding the NHS in Scotland, as we are doing in England; there is a £9.1 billion real-terms uplift in the Scottish budget over the period of the spending review. In England, integrated care boards are responsible for commissioning services to meet the health needs of their local population, and responsibility for providing community equipment to disabled people typically falls at the moment, as has been outlined, to local authorities. They have a statutory duty to make arrangements for the provision of community equipment to disabled people in their area. That equipment can be free for the recipient if the person is assessed as having eligible needs. Types of support include equipment to enable people to live more independently, such as grab rails, walking aids and wheelchairs for short-term use. Responsibility for managing the market for these services rests with local authorities. For people with long-term, complex mobility needs, support is provided by the national health service, based on assessed need. That may involve the provision of specialist equipment adapted to the specific needs of the individual, and can include both powered and manual wheelchairs.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  In the interest of time, I will not, but I think I know where the hon. Gentleman wants to go with this, with the NRS. I will be happy to write more fully—

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  Well, I have not got time. I will write more fully regarding his correspondence. I am genuinely disappointed, if it is true, that he has not been responded to since September. In addition, the 10-year plan makes a commitment to reviewing the complaints regulations. NHS England and the Department are developing those together to achieve better accountability. The Government are also taking wider action to support disabled people through the 10-year health plan. On neighbourhood health, the neighbourhood health service will support disabled people to have choice and control over their care. That includes increasing the uptake of personal health budgets, which provide individuals with that greater choice and control over how their health is assessed and their wellbeing needs are met. One aim is to have a neighbourhood health centre in each community, bringing the NHS, local authority and voluntary sectors together to create a holistic offer that meets people’s needs in the place that they are. We expect these services to be designed in a way that reflects the specific needs of disabled people, with a focus on personalised, co-ordinated care. I particularly think that this is an opportunity, as we move care from hospital to the community, to address some of the concerns raised in the debate today. On social care, the Government are also driving forward improvements for disabled people. We are enabling people to have more choice and control over their care—through greater use of direct payments, for example. We are also expanding care options to boost independent living at home and have recently confirmed £723 million for the disabled facilities grant in 2026-27. The total DFG budget across 2025-26 and 2026-27 is £150 million more than the total budget across the previous two years. That represents an 11% increase and will support more disabled people to get the vital home adaptations that they might need. The Better Care Fund, which took effect in April 2025, is a framework for ICBs and local authorities to make joint plans and pool budgets to deliver better joined-up care. That can include the provision of assistive technology and equipment, such as wheelchairs. This financial year, ICBs and local authorities plan to spend £440 million on assistive technology and equipment, and we have introduced care technology standards to help them to choose the right support. In addition, as we move from hospital to community, commissioners can, if they wish, think about better co-commissioning, transcending traditional boundaries between local authorities, social care and the NHS. I am grateful to the hon. Member for Aberdeenshire North and Moray East for securing this important debate and I want to respond to a question he asked. Whether we call it a strategy or a framework, there is a real opportunity at this time of change in the NHS—including the development of a national quality board at NHS England, which will come into the Department of Health and Social Care once NHS England is abolished —to genuinely think about how we define “quality” for disabled people and about the equipment and the spaces that they use. Again, I will be very happy to discuss that with my colleagues in charge of the quality board. I will write to the hon. Gentleman with specifics that we can perhaps tease out after this debate today. We recognise the life-changing impact that having timely access to suitable disability equipment can have on the lives of disabled people across the United Kingdom, in every nation. The Government are dedicated to ensuring that all disabled people have access to the services and support that they need to live a fulfilling life; the presence of disability Ministers in each Department is certainly progress in that regard. Our work to reform health and social care, alongside the new plan for disability, will also help us to achieve that.

• 11 Mar 2026 · Disability Equipment Provision · Hansard source

  More

  I am grateful to the right hon. Gentleman, and to those who raised this matter earlier in the debate. It does trouble me deeply that we have a situation in which equipment is going unused when there is that need in another part of the system. I actually feel that quite acutely. Hon. Members may know that I am a vascular surgeon; at times, unfortunately, some of my job involves having to amputate people’s limbs for end-stage vascular disease. I see for myself that transition from someone being able-bodied to needing assistance, and, where that assistance is not available, the impact that has, especially when people know there is this lack of productive exchange of equipment in the system highlighted by hon. Members today. I am therefore very happy to take the issue forward with my officials to see what can be done further to marry the demand and the supply together in the country. Regarding wheelchair provision, NHS England has developed policy guidance and legislation to support ICBs to commission effective, efficient and personalised wheelchair services. I again nod to the remarks from the hon. Member for Aberdeenshire North and Moray East on making sure we get better, more efficient and personalised service provision. In April 2025, NHS England published the wheelchair quality framework, developed in collaboration with the NHS England national wheelchair advisory group. The framework is designed to assist ICBs and NHS wheelchair service providers in delivering high-quality provision that offers improved access, outcomes and experience. NHS England introduced personal wheelchair budgets, including legal rights, in 2019, providing a clear framework for ICBs to commission personalised wheelchair services that are outcomes-focused and integrated. Those budgets give people greater choice over the wheelchairs that they are provided with. Additionally, the model service specification for wheelchairs sets out that wheelchair assessments should take place in the most suitable environment based on the needs of that individual. NHS England is aware, as am I, that several complaints have been made about the quality of services commissioned by some ICBs. NHS England is working through the appropriate regional teams to gain intelligence from those ICBs on quality concerns and contracting arrangements, to fully understand the issues being raised.

• 9 Mar 2026 · Funeral Directors: Regulation · Hansard source

  More

  I am grateful to the hon. Member for Gosport (Dame Caroline Dinenage) for securing this important debate and for her continued advocacy on behalf of her constituents. As the hon. Member for North Dorset (Simon Hoare) highlighted, I was here at this Dispatch Box not so long ago responding to him on the same topic. We all recognise the profound importance of ensuring dignity, safety and high quality standards of care for people during life and after they die. Bereaved families place immense trust in funeral directors to guide and support us through one of the most difficult and distressing times of our lives and to ensure that our loved ones are laid to rest with the utmost respect. They rightly expect that high standards, professional conduct and appropriate oversight are firmly in place. However, these deeply troubling cases, including the appalling events in the constituencies of the hon. Member for Gosport and of my hon. Friend the Member for Leeds South West and Morley (Mark Sewards), demonstrate that his trust cannot always be assumed. Although these cases are rare, they have revealed serious weaknesses in our system, as the hon. Member for Gosport has adumbrated this evening. Unacceptable and distressing incidents, such as bodies being stored or treated in ways that cause deep anguish, were able to occur. In some instances, the police lacked the powers they needed to act. In the case of Elkin and Bell, the two funeral directors in the hon. Lady’s constituency, charges included intentionally or recklessly causing a public nuisance, the common law offence of preventing the lawful and decent burial of a body, and carrying on a business with intent to defraud creditors or another fraudulent purpose. The Ministry of Justice is actively exploring options to strengthen criminal law protections for the deceased, including the potential for new offences as outlined in the Law Commission’s 14th programme of work. This work will identify gaps in the current law and whether new offences are needed to address behaviours that fail to treat a deceased person with dignity and respect. I am pleased to say that we have already taken steps to strengthen and improve standards to safeguard the security and dignity of the deceased. My Department is responsible for co-ordinating the Government’s response to phase 2 of the Fuller inquiry. In December 2025, the Government published our interim update, outlining the progress made against the 75 recommendations. Of those, 11 have been accepted in full, 43 are accepted in principle and 21 remain under consideration. The 11 recommendations accepted in full cover standards, data and operating procedures in the wider health sector. Highlights include the Human Tissue Authority’s publication of updated guidance on 1 December to ensure that adverse incidents in the anatomy sector are recorded, and NHS England’s agreement to introduce data collection on conveying deceased patients in ambulances for the first time in 2026-27. Since I was last here at the Dispatch Box responding to the hon. Member for North Dorset, the Human Tissue Authority has also issued universal and generic best practice guidance for those responsible for the care and dignity of the deceased, including organisations not formally regulated by the HTA. That point is particularly pertinent in relation to the hon. Member for Gosport’s comments about the increasing number of direct cremations. In addition, the HTA has begun reviewing its codes of practice. That process will continue into 2026-27. The review may lead to changes to the current guidance in light of the Fuller inquiry recommendations, and it will help us to consider whether the codes could be applied and used by other settings. Before turning to the discussion about the options to strengthen and improve standards to safeguard the security and dignity of the deceased, I want to remind the House how we got here. Following the unspeakable crimes committed by David Fuller, the last Government established an independent inquiry, sponsored by the Department of Health and Social Care, to investigate how a member of staff was able to carry out such unlawful and abhorrent acts in hospital mortuaries, and how those actions went unnoticed. I must make it clear that crimes such as David Fuller’s are extremely rare. However, that will come as little consolation to the families involved. At this point I extend my deepest sympathies to those families, who continue to bear the weight of suffering, and for whom it must be particularly triggering when debates such as this are held in the Chamber. Phase 1 of the inquiry focused on the crimes that Fuller committed in the mortuaries at Maidstone and Tunbridge Wells NHS trust. The phase 1 report, published in November 2023, identified failures of management, governance and regulation, as well as a lack of curiosity, which enabled Fuller to continue his repeat offending. It set out 16 recommendations for the trust and one for local councils. In February 2024, the trust published an assurance statement on the implementation of the recommendations from the report. Kent and East Sussex county councils reviewed the position and confirmed that their contracts with the trust required compliance with licensing and regulatory standards to ensure that the deceased were treated with dignity and respect. On 15 July 2025, the inquiry panel published its final phase 2 report, which dealt with the care of the deceased in both hospital and non-hospital settings. It acknowledged that arrangements for the care of deceased people are complex and often interconnected. It clearly identified multiple organisations, with different governance and operating models, spread across a large number of sectors. It focused on whether procedures and practices in hospital and non-hospital settings, including the funeral sector, were doing enough to safeguard the security of the deceased, and it considered the role of regulators. The overall recommendation of the inquiry’s chair, Sir Jonathan Michael, was for the Government to introduce an independent statutory regulatory regime to protect the security and dignity of people after death in all settings where deceased individuals are cared for, regardless of the institution, including funeral directors. Eleven of the phase 2 recommendations relate to the introduction of statutory regulation, including regulation of the funeral sector. They remain under consideration. Through the Fuller inquiry recommendations programme board, established in July last year, work continues apace with the Ministry of Justice, the Department for Business and Trade and the Ministry of Housing, Communities and Local Government to assess options for Government intervention to improve standards of care for the deceased in the funeral sector, and, as such, to respond to the recommendations.

• 9 Mar 2026 · Funeral Directors: Regulation · Hansard source

  More

  The hon. Gentleman is clearly reading my speech. I can assure him that meetings had taken place before my appointment as the Minister responsible for the aspects of the regulations relating to the Department of Health and Social Care. I can also confirm that further meetings are taking place, at my instruction, with the relevant Departments—hosted by me in the Department of Health and Social Care—so that we can genuinely move forward. I know that there is consensus across the House that we must move forward, genuinely and expediently, not only in aligning lines of demarcation and responsibility across those Departments, but in genuinely working together and showing leadership on this issue. I shall be happy to keep the hon. Members who are interested updated on those meetings when they take place. This is a complex and sensitive matter that requires careful and thoughtful consideration to safeguard the rights and dignity of those who have died, to support their bereaved families, and to ensure that any measures taken are proportionate, given that we are working with a number of small and medium-sized enterprises. To support this work, I am continuing to discuss progress and next steps with relevant Ministers across Government, as I said in response to the intervention from my hon. Friend the Member for Leeds South West and Morley (Mark Sewards). The Government are continuing to consider all options to ensure that high standards are upheld consistently across the funeral sector, and that includes the possibility of introducing suitable and proportionate regulation for funeral directors. As we discuss these options, we are clear about the need for the approach to maintain high standards, protect the dignity of the deceased and support bereaved families, recognising that any additional costs arising from regulation will ultimately fall on them. At the same time, we must consider the impact on the funeral sector itself. The funeral sector comprises 6,500 private businesses across the UK, the vast majority of which serve their communities with compassion and integrity, as we have heard tonight. Some 85% are already members of trade bodies that provide guidance, codes of practice and voluntary inspection schemes. The Government are committed to reducing the administrative burdens of regulation on businesses by 25%, and that will contribute to our approach to regulation in this area.

• 9 Mar 2026 · Funeral Directors: Regulation · Hansard source

  More

  I am very cognisant of that fact. We will discuss in our interministerial meetings how we can involve the profession early in that regard. While the vast majority of funeral directors already operate with professionalism, the actions of a small minority have undermined public confidence. We are determined to ensure the security, dignity and care of the deceased across all settings. That is why we are committed to setting out the Government’s decision on regulation in our full response to the Fuller inquiry phase 2 report in summer 2026. Question put and agreed to.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  I beg to move, That the Committee has considered the draft Human Medicines (Amendment) Regulations 2026. It is a pleasure to serve under your chairmanship, Mrs Harris. In response to the covid-19 pandemic, multiple temporary amendments were made to the Human Medicines Regulations 2012 in autumn 2020 to enable the roll-out of the covid-19 and influenza vaccination programmes. Those amendments were extended in 2022 and 2024 following public consultation, and are due to lapse on 1 April 2026. This instrument will retain several provisions within those regulations as permanent legislation and expand them to other vaccines. It is designed to build on the benefits that the amendments have provided to date, as well as the wider lessons learned during the pandemic and in recent polio and measles, mumps and rubella vaccine catch-up programmes. It will support the safe supply, distribution and administration of a wider group of vaccines, helping the ongoing development of a vaccination system that is fit for the future. I will briefly set out what each of the regulations does. Paragraphs (1) and (2) of regulation 3A enable trained healthcare professionals, or staff under the supervision of trained healthcare professionals, to conduct the final stage of assembly and preparation of covid-19 vaccines, without additional marketing authorisations or a manufacturer’s licence being required. That enabled the bulk assembly of covid-19 vaccines during the pandemic. Given the more targeted approach of recent covid-19 vaccination campaigns, this instrument allows the provisions in paragraphs (1) and (2) of regulation 3A to lapse from 1 April this year. Paragraphs (3) and (4) of regulation 3A permit holders of a wholesale dealer’s licence who do not hold a manufacturer’s licence to re-label covid-19 vaccines to reflect changes in shelf life resulting from product thawing. This instrument retains those provisions as permanent legislation, and expands them to include any vaccine against any infectious disease. That will enable a more efficient use of the capable vaccinator workforce, and will support further flexibilities in our supply chain. Regulation 19 allows covid-19 and influenza vaccines to be moved between different NHS service providers at the end of the supply chain, without the need for a wholesale dealer’s licence. This instrument retains those provisions as permanent legislation, and expands them to include any vaccine against any infectious disease, with relevant safeguards to regulate its use. That will ensure that vaccines can be rapidly deployed in exceptional circumstances in response to public health needs. Regulation 247A enables the use of an extended workforce who are legally and safely able to administer covid-19 or influenza vaccines without the input of a prescriber, using an approved protocol. This instrument allows regulation 247A to lapse from 1 April 2026, and introduces a new, permanent provision—regulation 235A —to continue the use of an extended vaccinator workforce through the introduction of a vaccine group direction. That will support the use of an extended workforce to administer any vaccine against any infectious disease where directed by a national body, and will ensure that the UK has the necessary agility and flexibility in its workforce to deliver those vaccinations. Regulation 233 enables persons lawfully conducting a retail pharmacy business to deliver covid-19 and influenza vaccination services off their registered premises, under a patient group direction. This instrument expands that provision to include any vaccine against an infectious disease. Additionally, to enable those services to continue after paragraphs (1) and (2) of regulation 3 lapse from 1 April this year, this instrument amends regulation 3 to enable pharmacists to prepare or assemble medicines for a patient in the course of their treatment without a manufacturer’s licence. That will ensure that community pharmacies can deliver vaccination services off their registered premises, enabling them to deliver targeted outreach programmes. Schedule 17 introduced a category of occupational health vaccinators, who are permitted under the written directions of a doctor to administer covid-19 and influenza vaccines as part of an NHS or local authority occupational health scheme. This instrument amends the list of professionals able to deliver OHS vaccinations, aligning it with the professionals able to supply medicines under a patient group direction. In addition, it expands the scope of schedule 17 to cover any vaccination or immunisation offered as part of an OHS. Those changes will improve access to vaccines for staff within and beyond the health and social care sector, protecting them in the vital roles that they do. In developing this statutory instrument, from 5 September to 28 November 2025, the Government conducted a public consultation on our proposals, hosted by the Department of Health and Social Care for England, Wales and Scotland, and jointly with the Department of Health for Northern Ireland, as medicines regulation is a transferred matter in Northern Ireland, and a reserved matter in Scotland and Wales. The consultation received 218 responses, from organisations and individuals sharing professional and personal views, the majority of which were supportive of the proposals. We received many positive comments about how the flexibilities within the regulations have helped to increase access and efficiency across the system, while effectively utilising the workforce that came into place to deliver covid-19 and influenza vaccinations following the covid-19 pandemic. The consultation posed 15 questions on the technical aspects of the regulations, and we saw broad agreement on each of those proposals. Given the technical nature of the questions and the limited time the Committee has to discuss this instrument, I will not provide an immediate analysis of each response here; however, the published Government response can be accessed on the gov.uk website. This instrument builds on the successes of the large-scale vaccination programmes during the covid-19 pandemic to support patient safety, improve access to and availability of vaccines, and ensure that the vaccine system continues to innovate. The changes will implement improvements that will help to facilitate the shift from “sickness to prevention”, as described in the Government’s 10-year health plan, helping to restore trust in vaccinations and ultimately increasing vaccine uptake. Regulations 3 and 8 will enable community pharmacies to play a bigger role in prevention by expanding their role in vaccine delivery and enabling targeted outreach in areas where health inequalities remain pervasive, and where evidence indicates that doing so is clinically appropriate and value for money. The changes will support the delivery of commitments on vaccination and immunisation frameworks in Scotland and Wales, and an instrument will be laid in the Northern Ireland Assembly in parallel to these regulations, to deliver changes to the vaccination system across the United Kingdom. To conclude, the instrument makes changes that will permanently support the safe supply, distribution and administration of a wider range of vaccines, and the proposals were supported by the majority of respondents to our consultation. I therefore commend the regulations to the Committee, and hope that hon. Members will support them.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  I will clarify that for the shadow Minister, but we are both cognisant of the wider point that clinicians ultimately take responsibility for prescriptions and informed consent of the vaccination process, and that will still continue. Healthcare professionals will still be seeking consent for treatment; the VGD simply means that they can be separate to the person who is then administering the vaccine in practice. There is no suggestion that there will not be clinical oversight or governance of this process—it is quite the opposite. This provision is designed to tighten governance frameworks and make them more transparent. As I set out at the start of the debate, the proposed amendments aim to support the ongoing development of a vaccination system that is fit for the future. They are designed to build upon the benefits that HMRs have provided to date, as well as wider lessons learned during the pandemic, including recent polio and MMR catch-up programmes. In amending these regulations, the Government are seeking to maintain important safety measures while also increasing the effectiveness of the system’s supply chains and workforce in vaccination programmes. The science unequivocally tells us that, after clean water, vaccination is the most effective public health intervention for saving lives and promoting good health. It is therefore a solemn duty of this Government to do all we can in this space to support the health system’s ability to deliver vaccines for all those eligible and, in turn, help support vaccine uptake. Given the overall support of the proposals in the consultation, and the ongoing need to support the continued safe and effective supply, distribution and administration of vaccines both now and in future, it is our intention to make permanent the provisions discussed during the debate. I commend the draft regulations to the Committee. Question put and agreed to.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  I am grateful to the shadow Minister for her support; she is a learned Member of this House, and I know she takes these matters extremely seriously both here and in her own clinical practice. She raised a technical point on whether the sub-paragraph should include the word “pharmacist”, given the updating of the regulations—I am very happy to explore that further to ensure that the wording is optimal. I also want to reassure her on the point she made about the workforce; training and a governance framework will be set up by the UK Health Security Agency, which will oversee all of this. Whether it is an operating department practitioner or anyone else, there will be a basal level of training that can reassure all Members of this House, whether we are the clinician prescribing the vaccination or the citizen receiving it. This will be overseen very tightly by the UKHSA.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  I am not clear on why they have been removed from the list. However, I certainly expect that anyone who is reasonably trained will be able to deliver vaccines in the settings that we have proposed, which include community hospitals and everywhere in between, when we need to think about hard-to-reach communities. The shadow Minister also asked a question on vaccine group direction versus patient group direction. The primary difference is that the VGD allows for the separation of the decisions to treat and provide consent by a registered healthcare professional, which still need to exist, from the administration of the vaccine, which is then done by a separate individual. That is not possible under a PGD, so it is about separating the roles. However, I reassure her that the consent process in prescriptions is paramount, and she is right that it must continue to be if we want to invite people’s confidence in the vaccination process.